ACE2 is present in Clara cells and in alveolar type II cells and it is damage to these cells that is a feature of acute respiratory distress syndrome (ARDS),77 which is seen in many severe COVID‐19 cases. This evidence concerns the gene ACE2 and acute respiratory distress syndrome.